About our research

The Ophthalmic Neuroscience Unit is a multidisciplinary team of researchers with expertise in mathematics, engineering, data science, ophthalmology and neuroscience, who are focused on new ways to image the retina. By applying hyperspectral imaging to the eye, the group has discovered imaging biomarkers for a number of diseases, including including the first in-human retinal biomarker for Alzheimer’s disease.

In parallel, the team has developed a hyperspectral camera that they hope to make available in every optometry and ophthalmology clinic to improve the detection of Alzheimer’s disease as well as a range of sight-threatening eye diseases.

What you’ll see

• Timeline of the hyperspectral camera being developed
• A demonstration of Cross Modality Annotation Software (XMAS) to get a deeper look into the layers of 3D imaging.

Talk to us about

• Can hyperspectral retinal imaging be used to identify novel features of eye diseases, including predictors of progression?
• Can hyperspectral retinal imaging be used to detect people who are at risk of Alzheimer’s disease before the onset of dementia?
• Can hyperspectral retinal imaging be used to monitor disease progression and treatment responses in Alzheimer’s disease?